About Organamet Bio

Pioneers of regenerative cardiac medicine

Founded to end the donor shortage and the era of symptom-only care — building first-in-class therapies that repair, regenerate, and ultimately replace the failing heart.

Our mission

Save lives by transforming heart-failure care — at every stage

Heart disease is the world's leading cause of death, yet most of medicine still only manages its symptoms. We exist to change that.

Our goal

Advance a sequential pipeline of first-in-class bioengineered therapies — led by Lami-Pro™ for heart failure with preserved ejection fraction (HFpEF) — that reaches patients quickly while building toward a fully bioengineered, personalized human heart.

Our approach

Launch products sequentially to generate early revenue and platform validation, fund the next breakthrough, and build a defensible IP estate spanning products, manufacturing, and delivery.

Leadership

A team that has repaired, decellularized, and rebuilt the heart

Dr. Doris Taylor

Dr. Doris Taylor

Founder, CEO & Board Chair

A pioneer of regenerative medicine with 30+ years in the field. Credited with the first functional cardiac repair with stem cells (1998) and perfusion decellularization (2008, Nature Medicine) — named a "Top 10 Research Advance" by the American Heart Association. Nominated to TIME's 100 Most Influential People (2009). Co-founder of Miromatrix Medical and Organamet Bio, and a longtime leader of regenerative-medicine research programs.

Dr. Luiz Sampaio

Dr. Luiz Sampaio

Founder & Chief Medical Officer

Cardiothoracic surgeon with 20+ years in cardiovascular research. Former Chief Medical Officer at an LVAD startup, leading clinical translation and regulatory strategy across cardiovascular device and biologic programs.

Diana Morales

Diana Morales

VP / Director of Strategic Alliances

Commercial strategist driving investor relations, market access, and strategic partnership development — connecting the company's science to capital and commercialization partners.

Eric Finley

Eric Finley

Interim CFO

Venture Partner and Managing Director of Manifest Capital Holdings LLC (MCH LLC), a St. Kitts and Nevis-based management consulting and investment advisory company.

Board & advisors

Guided by leaders in medicine, science, and capital

Our board and advisory network spans clinical cardiology, regenerative science, advanced manufacturing, and finance.

Michael Golway, PE

Michael Golway, PE

Board Member

CEO / President, Advanced Solutions Life Sciences.

Dr. Leslie Miller

Dr. Leslie Miller

Scientific Advisor

Transplant Cardiologist, University of Florida. Former President, International Society of Heart and Lung Transplantation.

Greg Downey

Greg Downey

Strategic / Financial Advisor

Managing Director, Purim Ventures.

Desiree Vrionedes Freris

Desiree Vrionedes Freris

Strategic Advisor

HLHS Parent & Advocate. Founder of Building the Cure Foundation.

Strategic partners

Backed by DoW-funded advanced manufacturing

ARMI | BioFabUSA

A DoW-funded consortium of 150+ organizations led by Dean Kamen, and Organamet's R&D and manufacturing home in Manchester, New Hampshire.

Advanced Solutions Life Sciences

Creators of the BioAssemblyBot® robotics and physical-AI platform that powers automated, scalable heart fabrication.

DEKA Research

Engineering and device-development collaboration within the Kamen-led innovation ecosystem.